Moylan, PA, United States of America

Robert W Colman


Average Co-Inventor Count = 2.4

ph-index = 6

Forward Citations = 114(Granted Patents)


Location History:

  • Philadelphia, PA (US) (1990 - 1991)
  • Media, PA (US) (2001)
  • Moylan, PA (US) (1989 - 2008)

Company Filing History:


Years Active: 1989-2008

Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Robert W. Colman

Introduction

Robert W. Colman is a notable inventor based in Moylan, PA (US), recognized for his significant contributions to the field of medical science. With a total of 11 patents to his name, Colman's work primarily focuses on the treatment of diseases through innovative antibody therapies.

Latest Patents

Colman's latest patents include groundbreaking research on the treatment of diseases with antibodies against high molecular weight kininogen domain 5. His patents detail how antibodies directed against an antigenic determinant of high molecular weight kininogen domain 5, particularly those located in the region formed by light chain amino acids Gly(440) to Lys(502), can inhibit angiogenesis. This inhibition of angiogenesis is crucial for developing therapies for various diseases, showcasing the potential impact of his work.

Career Highlights

Throughout his career, Robert W. Colman has made significant strides in medical research. His innovative approaches have led to advancements in understanding how specific antibodies can be utilized in therapeutic settings. His work has been instrumental in paving the way for new treatment options in the medical field.

Collaborations

Colman has collaborated with esteemed colleagues such as Shaker Ahmed Mousa and Alvin H. Schmaier. These partnerships have further enriched his research and contributed to the success of his innovative projects.

Conclusion

Robert W. Colman's contributions to medical science through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to inspire advancements in disease treatment and antibody research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…